Summary

The global body contouring treatments market is expected to reach USD 2.58 billion by 2029 from USD 1.46 billion in 2024, at a CAGR of 10.0% from 2024 to 2029. Increase in acceptance of aesthetic procedures, coupled with personalized and flexible financing plans has increased the demand for these products. Growing interest in anti-aging procedures are more prevalent in aging population. Body contouring procedures helps to reshape and improvesconfidence. Moreover,increased benefits of minimally invasive and non-invasive body contouring procedures have driven demand for body contouring treatments market.

“The non-invasive technologies segment of technology segment held the largest share of the market in 2023”
The body contouring treatments market is segmented based on technology into invasive technologies and non-invasive technologies. The non-invasive technologies accounted for a major share in 2023. Increase in technological innovations, rise in advertisement, and the rising adoption of devices due to less incisions is anticipated to fuel the growth of the segment. Treatments for non-invasive body contouring that involve radiofrequency, ultrasound, cryolipolysis (freezing fat), and laser-based techniques have significantly improved in tems of safety and effectiveness. These technologies have a wide range of benefits, which contribute to the non-invasive treatment popularity among individuals.

“The non-surgical fat reduction segment of application segment held the largest share of the market in 2023”
The body contouring treatments market can be segmented based on application into abdominoplasty, liposuction, non-invasive fat reduction, cellulite treatment, and other applications. Increasing number of beauty centers and rising adoption mainly due to improved accuracy and better outcomes drives the market. The non-surgical fat reduction treatments are gaining popularity across all patient types and ages. Hence, broader acceptance for treatment procedures due to innovative technologies supports the surge in demand that further drives the growth for the non-surgical fat reduction segment.

“The female patients segment for patient type segment to hold the largest market share in 2023”.
Based on patient type , the body contouring treatments market is segmented into female patients and male patients. Female patients is the major segment, accounting for the largest body contouring treatments market share in 2023. The increase in awareness about non-invasive body contouring procedures, rise in post-pregnancy body reconstruction procedures, increase in influencer endorsements, and social media promotion supports the growth of the segment.

“The aesthetic clinics segment for the end user segment is projected to register a significant CAGR during the forecast period.”
The body contouring treatments market is segmented by end-users into hospitals, aesthetic clinics, and medical spas & beauty centers. The hospitals accounted for a major end-user market share in 2023. The increase in spending on body shaping procedures and rise in medical tourism, and rising disposable income per capita is anticipated to propel the segment growth. Furthermore, rising adoption of new and improved devices in the hopsitals is expected to support the growth of this segment.

“The market in the Asia Pacific region is expected to witness the highest growth during the forecast period.”
The north america region accounted for major share in 2023. Asia pacific region to grow at the highest CAGR in body contouring treatments market. Healthcare infrastructure and service investments, especially in the emerging economies, are fostering the development of medical aesthetics, which leads to growing demand for body contouring. In this regard, market leaders have increased their efforts to strengthen their presence in the Asia Pacific market to meet the ever-growing requirement for body contouring treatment. The availability and accessibility of the service in this market have also been enhanced by the increasing presence of aesthetic clinics, particularly in the APAC region.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–30%, Tier 2–42%, and Tier 3– 28%
• By Designation: Director-level–10%, C-level–14%, and Others–76%
• By Region: North America–40%, Europe–30%, Asia Pacific–22%, Latin America–6%, and RoW- 10%
The prominent players in the body contouring treatments market are as AbbVie Inc. (US), InMode Ltd. (Israel), Bausch Health Companies Inc. (Canada), Cynosure Lutronic (US), Venus Concept (Canada), EL.EN.S.P.A (Italy), Sisram Medical Ltd. (Israel), BTL Industries(UK), Sharplight Technologies Inc. (Canada), Sciton Inc. (US), Candela Corporation (US), Fotona (Solvenia )
The study includes as in-depth competitive analysis of these key players in the authentication and brand protection market, with their company profiles recent developments,and key market stratergies

Research Coverage

This report studies the body contouring treatments market based on technology, application, patient type, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will help market leaders and new entrants with information on the closest approximations of the revenue numbers for the overall body contouring treatments market and the subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

This report provides insights on the following pointers:
• Analysis of key drivers (Growing adoption for minimally invasive and non-invasive body contouring procedure, increasing demand for aesthetic treatments among men, rising adoption of new and innovative body contouring technologies , broad acceptance of aesthetic procedure and growing attention on appearance and body image), restraints (high cost of treatment and inadequate reimbursement policies), opportunities (growth potential in emerging economies), and challenges (social and cultural barrriers in emerging economies, stringent regulatory compliance and safety standards) influencing the growth of the body contouring treatments market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the body contouring treatments market
• Market Development: Comprehensive information about lucrative markets–the report analyses the body contouring treatments market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the body contouring treatments market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players, such as AbbVie Inc. (US), Inmode Ltd. (Israel), Bausch Health Companies Inc. (Canada), Cynosure Lutronic (US), Sisram Medical Ltd (Israel)

ページTOPに戻る

Table of Contents

1 INTRODUCTION 25
1.1 STUDY OBJECTIVES 25
1.2 MARKET DEFINITION 25
1.3 INCLUSIONS AND EXCLUSIONS 26
1.4 STUDY SCOPE 27
1.4.1 MARKETS COVERED 27
1.4.2 YEARS CONSIDERED 28
1.4.3 CURRENCY CONSIDERED 28
1.5 STAKEHOLDERS 28
1.6 IMPACT OF AI/GEN AI 28
2 RESEARCH METHODOLOGY 29
2.1 RESEARCH DATA 29
2.1.1 SECONDARY DATA 29
2.1.1.1 Key sources for secondary research 29
2.1.2 PRIMARY DATA 30
2.1.2.1 Key primary sources 31
2.1.2.2 Key industry insights 32
2.1.2.3 Breakdown of primary interviews 32
2.2 MARKET SIZE ESTIMATION 33
2.2.1 BOTTOM-UP APPROACH 34
2.2.1.1 Company revenue estimation approach 35
2.2.1.2 Customer-based market estimation 36
2.2.1.3 Growth forecast approach 37
2.2.1.4 CAGR projections 37
2.3 DATA TRIANGULATION 37
2.4 MARKET SHARE ANALYSIS 38
2.5 RESEARCH ASSUMPTIONS 39
2.5.1 PARAMETRIC ASSUMPTIONS 39
2.5.2 GROWTH RATE ASSUMPTIONS 39
2.6 RESEARCH LIMITATIONS 40
2.7 RISK ASSESSMENT 40
3 EXECUTIVE SUMMARY 41
4 PREMIUM INSIGHTS 45
4.1 BODY CONTOURING TREATMENTS MARKET OVERVIEW 45
4.2 NORTH AMERICA: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY 46
4.3 ASIA PACIFIC: BODY CONTOURING TREATMENTS MARKET, BY END USER 46
4.4 EUROPE: BODY CONTOURING TREATMENTS MARKET, BY APPLICATION 47
4.5 GEOGRAPHIC SNAPSHOT OF BODY CONTOURING TREATMENTS MARKET 48
5 MARKET OVERVIEW 49
5.1 INTRODUCTION 49
5.2 MARKET DYNAMICS 49
5.2.1 DRIVERS 50
5.2.1.1 Growing adoption of minimally invasive and non-invasive body contouring procedures 50
5.2.1.2 Increasing demand for aesthetic treatments among men 51
5.2.1.3 Rising adoption of new and innovative body contouring technologies 52
5.2.1.4 Widespread social media influence and cultural changes 52
5.2.2 RESTRAINTS 53
5.2.2.1 High cost of treatment and inadequate reimbursement policies 53
5.2.3 OPPORTUNITIES 53
5.2.3.1 Growth potential in emerging economies 53
5.2.4 CHALLENGES 55
5.2.4.1 Social and cultural barriers 55
5.2.4.2 Stringent regulatory compliance and safety standards 55
5.3 VALUE CHAIN ANALYSIS 56
5.3.1 RESEARCH & PRODUCT DEVELOPMENT 57
5.3.2 RAW MATERIAL PROCUREMENT AND MANUFACTURING 57
5.3.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES 57
5.4 SUPPLY CHAIN ANALYSIS 57
5.4.1 MANUFACTURERS 58
5.4.1.1 Prominent companies 58
5.4.1.2 Small and medium-sized enterprises 58
5.4.2 END USERS 58
5.5 ECOSYSTEM ANALYSIS 59
5.6 REGULATORY LANDSCAPE 60
5.6.1 REGULATORY ANALYSIS 60
5.6.1.1 North America 60
5.6.1.1.1 US 60
5.6.1.1.2 Canada 63
5.6.1.2 Europe 64
5.6.1.3 Asia Pacific 67
5.6.1.3.1 Japan 67
5.6.1.3.2 China 67
5.6.1.3.3 India 69
5.6.1.4 Latin America 69
5.6.1.4.1 Brazil 69
 
5.6.2 REGULATORY APPROVALS 70
5.6.3 KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 70
5.7 REIMBURSEMENT SCENARIO ANALYSIS 73
5.8 INVESTMENT AND FUNDING SCENARIO 74
5.9 PRICING ANALYSIS 75
5.9.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TECHNOLOGY 76
5.9.2 AVERAGE SELLING PRICE TREND OF BODY CONTOURING DEVICES, BY REGION 77
5.10 TRADE ANALYSIS 78
5.10.1 IMPORT DATA 79
5.10.2 EXPORT DATA 80
5.11 PATENT ANALYSIS 81
5.12 PORTER’S FIVE FORCES ANALYSIS 83
5.12.1 THREAT OF NEW ENTRANTS 84
5.12.2 THREAT OF SUBSTITUTES 84
5.12.3 BARGAINING POWER OF SUPPLIERS 84
5.12.4 BARGAINING POWER OF BUYERS 84
5.12.5 INTENSITY OF COMPETITIVE RIVALRY 84
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 85
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 85
5.13.2 KEY BUYING CRITERIA 86
5.14 KEY CONFERENCES AND EVENTS, 2024–2025 87
5.15 CASE STUDY ANALYSIS 88
5.15.1 IMPROVED FAT REDUCTION PROCEDURES USING LARGER APPLICATOR 88
5.15.2 ENHANCED SUPPLY CHAIN AND OPERATIONAL EFFICIENCY WITH HIGHER RESEARCH & DEVELOPMENT 89
5.16 TECHNOLOGY ANALYSIS 89
5.16.1 KEY TECHNOLOGIES 89
5.16.1.1 Thermal technologies 89
5.16.1.2 Non-thermal technologies 90
5.16.2 COMPLEMENTARY TECHNOLOGIES 90
5.16.2.1 Skin cooling systems 90
5.16.3 ADJACENT TECHNOLOGIES 91
5.16.3.1 Treatment planning software 91
5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 91
5.18 UNMET NEEDS 92
5.19 IMPACT OF AI/GEN AI ON BODY CONTOURING TREATMENTS MARKET 93
5.19.1 KEY USE CASES 94
 
6 BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY 95
6.1 INTRODUCTION 96
6.2 INVASIVE TECHNOLOGIES 96
6.2.1 INVASIVE RADIOFREQUENCY TECHNOLOGY 97
6.2.1.1 Growing inclination toward skin tightening to propel market 97
6.2.2 INVASIVE LASER TECHNOLOGY 98
6.2.2.1 Higher advantages compared to traditional techniques to speed up growth 98
6.2.3 INVASIVE ULTRASOUND TECHNOLOGY 99
6.2.3.1 Targeted fat reduction and minimal discomfort to augment growth 99
6.3 NON-INVASIVE TECHNOLOGIES 100
6.3.1 NON-INVASIVE RADIOFREQUENCY TECHNOLOGY 102
6.3.1.1 Rising use of cellulite treatment, fat reduction, and skin tightening to drive market 102
6.3.2 NON-INVASIVE LASER TECHNOLOGY 103
6.3.2.1 Growing adoption in hospitals and aesthetic clinics to fuel market 103
6.3.3 NON-INVASIVE ULTRASOUND TECHNOLOGY 103
6.3.3.1 Need for precise temperature management control to accelerate growth 103
6.3.4 CRYOLIPOLYSIS TECHNOLOGY 104
6.3.4.1 Low risk and minimal side effects to facilitate growth 104
6.3.5 OTHER NON-INVASIVE TECHNOLOGIES 105
7 BODY CONTOURING TREATMENTS MARKET, BY GENDER 107
7.1 INTRODUCTION 108
7.2 FEMALE PATIENTS 108
7.2.1 GROWING USE OF BODY CONTOURING TO ADDRESS POST-SURGICAL CHANGES TO BOOST MARKET 108
7.3 MALE PATIENTS 109
7.3.1 INCREASING SHIFT IN SOCIAL AND AESTHETIC STANDARDS TO EXPEDITE GROWTH 109
8 BODY CONTOURING TREATMENTS MARKET, BY APPLICATION 111
8.1 INTRODUCTION 112
8.2 NON-SURGICAL FAT REDUCTION 112
8.2.1 GROWING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO FUEL MARKET 112
8.3 CELLULITE REDUCTION 114
8.3.1 RISING OBESITY RATES TO SUPPORT MARKET GROWTH 114
8.4 LIPOSUCTION 114
8.4.1 GROWING DEMAND FOR COSMETIC ENHANCEMENT WITH SHORTER RECOVERY TIMES TO DRIVE MARKET 114
 
8.5 ABDOMINOPLASTY 115
8.5.1 INCREASING DESIRE FOR AESTHETIC IMPROVEMENTS TO PROMOTE GROWTH 115
8.6 OTHER APPLICATIONS 116
9 BODY CONTOURING TREATMENTS MARKET, BY END USER 118
9.1 INTRODUCTION 119
9.2 HOSPITALS 119
9.2.1 BOOMING MEDICAL TOURISM TO CONTRIBUTE TO MARKET GROWTH 119
9.3 AESTHETIC CLINICS 120
9.3.1 GROWING ESTABLISHMENT OF SPECIALTY CLINICS TO DRIVE MARKET 120
9.4 MEDICAL SPAS & BEAUTY CENTERS 121
9.4.1 RISING FOCUS ON BODY APPEARANCE TO AID GROWTH 121
10 BODY CONTOURING TREATMENTS MARKET, BY REGION 123
10.1 INTRODUCTION 124
10.2 NORTH AMERICA 124
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 129
10.2.2 US 130
10.2.2.1 Growing public acceptance of body contouring procedures to drive market 130
10.2.3 CANADA 132
10.2.3.1 Rising inclination toward reducing signs of aging to aid growth 132
10.3 EUROPE 134
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 138
10.3.2 GERMANY 139
10.3.2.1 Increasing volume of aesthetic procedures to drive market 139
10.3.3 FRANCE 141
10.3.3.1 Increasing demand for age-related aesthetic treatments to spur growth 141
10.3.4 UK 143
10.3.4.1 Rising focus of men on body aesthetics to encourage growth 143
10.3.5 ITALY 145
10.3.5.1 Gowing adoption of surgical procedures among young females to boost market 145
10.3.6 SPAIN 147
10.3.6.1 Growing availability of high-quality and effective products to fuel market 147
10.3.7 REST OF EUROPE 149
10.4 ASIA PACIFIC 150
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 154
10.4.2 JAPAN 156
10.4.2.1 Presence of medical aesthetic associations to spur growth 156
 
10.4.3 CHINA 158
10.4.3.1 Increased availability of cosmetic surgery apps and online services to support growth 158
10.4.4 INDIA 160
10.4.4.1 Increasing disposable income to contribute to market growth 160
10.4.5 AUSTRALIA 162
10.4.5.1 Favorable government initiatives to promote growth 162
10.4.6 SOUTH KOREA 164
10.4.6.1 Rising influx of foreign patients to facilitate growth 164
10.4.7 REST OF ASIA PACIFIC 166
10.5 LATIN AMERICA 168
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 170
10.5.2 BRAZIL 172
10.5.2.1 Heightened awareness regarding body contouring enhancements to stimulate growth 172
10.5.3 MEXICO 174
10.5.3.1 Increase in patient inflow from US to sustain growth 174
10.5.4 REST OF LATIN AMERICA 176
10.6 MIDDLE EAST & AFRICA 178
10.6.1 GROWING AVAILABILITY OF HIGH-QUALITY TREATMENTS TO DRIVE MARKET 178
10.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 181
11 COMPETITIVE LANDSCAPE 183
11.1 OVERVIEW 183
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 183
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN BODY CONTOURING TREATMENTS MARKET 183
11.3 REVENUE SHARE ANALYSIS, 2019−2023 185
11.4 MARKET SHARE ANALYSIS, 2023 186
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 188
11.5.1 STARS 188
11.5.2 EMERGING LEADERS 188
11.5.3 PERVASIVE PLAYERS 188
11.5.4 PARTICIPANTS 188
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 190
11.5.5.1 Company footprint 190
11.5.5.2 Technology footprint 191
11.5.5.3 Gender footprint 192
11.5.5.4 Application footprint 193
11.5.5.5 End-user footprint 194
11.5.5.6 Region footprint 195
 
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 195
11.6.1 PROGRESSIVE COMPANIES 195
11.6.2 RESPONSIVE COMPANIES 195
11.6.3 DYNAMIC COMPANIES 196
11.6.4 STARTING BLOCKS 196
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 197
11.7 COMPANY VALUATION AND FINANCIAL METRICS 199
11.7.1 COMPANY VALUATION 199
11.7.2 FINANCIAL METRICS 199
11.8 BRAND/PRODUCT COMPARISON 200
11.9 COMPETITIVE SCENARIO 200
11.9.1 PRODUCT LAUNCHES AND APPROVALS 200
11.9.2 DEALS 203
11.9.3 EXPANSIONS 204
12 COMPANY PROFILES 205
12.1 KEY PLAYERS 205
12.1.1 ABBVIE INC. 205
12.1.1.1 Business overview 205
12.1.1.2 Products offered 206
12.1.1.3 Recent developments 207
12.1.1.3.1 Product launches and approvals 207
12.1.1.4 MnM view 207
12.1.1.4.1 Key strengths 207
12.1.1.4.2 Strategic choices 207
12.1.1.4.3 Weaknesses and competitive threats 207
12.1.2 INMODE LTD. 208
12.1.2.1 Business overview 208
12.1.2.2 Products offered 209
12.1.2.3 Recent developments 210
12.1.2.3.1 Product launches and approvals 210
12.1.2.3.2 Deals 211
12.1.2.4 MnM view 211
12.1.2.4.1 Key strengths 211
12.1.2.4.2 Strategic choices 211
12.1.2.4.3 Weaknesses and competitive threats 211
12.1.3 BAUSCH HEALTH COMPANIES INC. 212
12.1.3.1 Business overview 212
12.1.3.2 Products offered 213
12.1.3.3 Recent developments 214
12.1.3.3.1 Product launches and approvals 214
12.1.3.4 MnM view 214
12.1.3.4.1 Key strengths 214
12.1.3.4.2 Strategic choices 214
12.1.3.4.3 Weaknesses and competitive threats 214
12.1.4 CYNOSURE LUTRONIC 215
12.1.4.1 Business overview 215
12.1.4.2 Products offered 215
12.1.4.3 Recent developments 216
12.1.4.3.1 Deals 216
12.1.4.4 MnM view 216
12.1.4.4.1 Key strengths 216
12.1.4.4.2 Strategic choices 216
12.1.4.4.3 Weaknesses and competitive threats 216
12.1.5 SISRAM MEDICAL LTD 217
12.1.5.1 Business overview 217
12.1.5.2 Products offered 218
12.1.5.3 Recent developments 219
12.1.5.3.1 Product launches and approvals 219
12.1.5.3.2 Deals 219
12.1.5.3.3 Expansions 219
12.1.5.4 MnM view 220
12.1.5.4.1 Key strengths 220
12.1.5.4.2 Strategic choices 220
12.1.5.4.3 Weaknesses and competitive threats 220
12.1.6 CUTERA, INC. 221
12.1.6.1 Business overview 221
12.1.6.2 Products offered 221
12.1.6.3 Recent developments 222
12.1.6.3.1 Product launches and approvals 222
12.1.7 EL.EN. S.P.A. 223
12.1.7.1 Business overview 223
12.1.7.2 Products offered 223
12.1.7.2.1 Product launches and approvals 225
12.1.8 VENUS CONCEPT 226
12.1.8.1 Business overview 226
12.1.8.2 Products offered 228
12.1.8.3 Recent developments 229
12.1.8.3.1 Product launches and approvals 229
12.1.8.3.2 Deals 230
12.1.9 SHARPLIGHT TECHNOLOGIES INC. 231
12.1.9.1 Business overview 231
12.1.9.2 Products offered 231
12.1.9.3 Recent developments 232
12.1.9.3.1 Product launches and approvals 232
12.1.10 SCITON 233
12.1.10.1 Business overview 233
12.1.10.2 Products offered 233
12.1.10.3 Recent developments 233
12.1.10.3.1 Product launches and approvals 233
12.1.11 CANDELA CORPORATION 234
12.1.11.1 Business overview 234
12.1.11.2 Products offered 234
12.1.11.3 Recent developments 235
12.1.11.3.1 Deals 235
12.1.12 BTL INDUSTRIES 236
12.1.12.1 Business overview 236
12.1.12.2 Products offered 236
12.1.12.3 Recent developments 237
12.1.12.3.1 Product launches and approvals 237
12.1.12.3.2 Deals 237
12.1.13 FOTONA 238
12.1.13.1 Business overview 238
12.1.13.2 Products offered 238
12.1.13.3 Recent developments 239
12.1.13.3.1 Product launches and approvals 239
12.1.14 GZ MTS ELECTRONICS CO., LTD. 240
12.1.14.1 Business overview 240
12.1.14.2 Products offered 240
12.1.15 ROHRER AESTHETICS, INC. 243
12.1.15.1 Business overview 243
12.1.15.2 Products offered 243
12.1.15.3 Recent developments 244
12.1.15.3.1 Product launches and approvals 244
12.1.15.3.2 Deals 244
12.2 OTHER PLAYERS 245
12.2.1 GBS INTERNATIONAL HOLDING LTD. 245
12.2.2 SINCLAIR 246
12.2.3 THERMI 247
12.2.4 YOLO MEDICAL INC. 247
12.2.5 DOMINION AESTHETIC TECHNOLOGIES, INC. 248
12.2.6 ZIMMER MEDIZIN SYSTEME GMBH 249
12.2.7 ERCHONIA CORPORATION 250
12.2.8 CLASSYS INC. 251
12.2.9 WON TECH CO., LTD. 252
12.2.10 CELLSOUND AESTHETICS 253
13 APPENDIX 254
13.1 DISCUSSION GUIDE 254
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 258
13.3 CUSTOMIZATION OPTIONS 260
13.4 RELATED REPORTS 260
13.5 AUTHOR DETAILS 261